Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing

Inhibition of B-Raf/MEK/ERK signaling is an effective therapeutic strategy against certain types of cancers such as melanoma and thyroid cancer. While demonstrated to be effective anticancer agents, B-Raf or MEK inhibitors have also been associated with early tumor progression and development of sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, You-Take, Deng, Jiusheng, Yue, Ping, Owonikoko, Taofeek K., Khuri, Fadlo R., Sun, Shi-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604000/
https://www.ncbi.nlm.nih.gov/pubmed/25867065
http://dx.doi.org/10.1038/onc.2015.97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604000/
https://www.ncbi.nlm.nih.gov/pubmed/25867065
http://dx.doi.org/10.1038/onc.2015.97

Ejemplares similares